{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T20:01:07Z","timestamp":1759694467288},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1007\/bf03040356","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T02:37:03Z","timestamp":1242182223000},"page":"380-384","source":"Crossref","is-referenced-by-count":4,"title":["Indikation und praktische Durchf\u00fchrung der parenteralen Eisentherapie","Intravenous iron therapy"],"prefix":"10.1007","volume":"115","author":[{"given":"Markus","family":"Kosch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland M.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03040356_CR1","first-page":"84","volume":"13","author":"KU Eckardt","year":"2001","unstructured":"Eckardt KU (2001) Anemia in critical illness. Wien Klin Wochenschr 13: 84\u201389","journal-title":"Wien Klin Wochenschr"},{"key":"BF03040356_CR2","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM197405302902201","volume":"290","author":"DA Lipschitz","year":"1974","unstructured":"Lipschitz DA, Cook JD, Finch CA (1974) A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med 290: 1213\u20131216","journal-title":"N Engl J Med"},{"key":"BF03040356_CR3","first-page":"227","volume":"25","author":"J Flament","year":"1986","unstructured":"Flament J, Goldmann M, Waterlot Y, Dupont E, Wybran J, Vanherweghem JL (1986) Impairment of phagocyte oxidative metabolism in haemodialyzed patients with iron overload. Clin Nephrol 25: 227\u2013230","journal-title":"Clin Nephrol"},{"key":"BF03040356_CR4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/oxfordjournals.ndt.a027248","volume":"11","author":"WH H\u00f6rl","year":"1996","unstructured":"H\u00f6rl WH, Cavill I, Macdougall IC, Schaefer RM, Sunder-Plassmann G (1996) How to diagnose and correct iron deficiency during r-HuEPO therapy \u2014 a conensus report. Nephrol Dial Transplant 11: 246\u2013250","journal-title":"Nephrol Dial Transplant"},{"key":"BF03040356_CR5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1515\/jpme.1995.23.1-2.83","volume":"23","author":"RM Schaefer","year":"1995","unstructured":"Schaefer RM, Schaefer L (1995) The hypochromic red cell: a new parameter for the monitoring of iron supplementation during r-HuEPO therapy. J Perinat Med 23: 83\u201388","journal-title":"J Perinat Med"},{"key":"BF03040356_CR6","doi-asserted-by":"crossref","unstructured":"European best practice guidelines for the management of anaemia in patients with chronic renal failure (1999) Nephrol Dialys Transplant 14: 1\u201350","DOI":"10.1093\/ndt\/14.suppl_2.61"},{"key":"BF03040356_CR7","first-page":"248","volume":"1","author":"A Shimalds","year":"1982","unstructured":"Shimalds A (1982) Adverse reactions to total dose infusion of iron dextran. Clin Pharm 1: 248\u2013249","journal-title":"Clin Pharm"},{"key":"BF03040356_CR8","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1001\/jama.1980.03300430028018","volume":"243","author":"RD Hamstra","year":"1980","unstructured":"Hamstra RD, Block MH, Schocket AL (1980) Intravenous iron dextran in clinical medicine. JAMA 243: 1726\u20131731","journal-title":"JAMA"},{"key":"BF03040356_CR9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69119.x","volume":"69","author":"DL Burns","year":"1999","unstructured":"Burns DL, Pomposelli JJ (1999) Toxicity of parenteral iron dextran therapy. Kidney Int 69: 119\u2013124","journal-title":"Kidney Int"},{"key":"BF03040356_CR10","first-page":"566","volume":"111","author":"M Auerbach","year":"1988","unstructured":"Auerbach M, Witt D, Toler W, Fierstein M, Lerner RG, Ballard H (1988) Clinical use of the total dose intravenous infusion of iron dextran. J Lab Clin Med 111: 566\u2013570","journal-title":"J Lab Clin Med"},{"key":"BF03040356_CR11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0272-6386(96)90463-1","volume":"28","author":"S Fishbane","year":"1996","unstructured":"Fishbane S, Ungureanu VD, Maeseka JK et al (1996) The safety of intravenous iron dextran in hemodialysis patients. Am J Kidney Dis 28: 529\u2013534","journal-title":"Am J Kidney Dis"},{"key":"BF03040356_CR12","first-page":"241","volume":"17","author":"G Sunder-Plassmann","year":"1997","unstructured":"Sunder-Plassmann G, H\u00f6rl WH (1997) Safety aspects of parenteral iron in patients with end-stage renal disease. Drug Experience 17: 241\u2013250","journal-title":"Drug Experience"},{"key":"BF03040356_CR13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/ajkd.2002.33917","volume":"40","author":"RA Zager","year":"2002","unstructured":"Zager RA, Johnson ACM, Hanson SY, Wasse H (2002) Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury. Am J Kidney Dis 40: 90\u2013103","journal-title":"Am J Kidney Dis"},{"key":"BF03040356_CR14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1523-1755.2003.00703.x","volume":"63","author":"DW Coyne","year":"2003","unstructured":"Coyne DW, Adkinson F, Nissenson AR, et al (2003) Sodium ferric gluconate complex in hemodialysis patients. Adverse reactions in iron dextran-sensitive and dextrantolernt patients. Kidney Int 63: 217\u201324","journal-title":"Kidney Int"},{"key":"BF03040356_CR15","first-page":"528","volume":"128","author":"R Hoigne","year":"1998","unstructured":"Hoigne R, Breymann C, K\u00fcnzi UP, Brunner F (1998) Parenterale Eisentherapie: Probleme und m\u00f6gliche L\u00f6sungen. Schweiz Med Wochenschau 128: 528\u2013535","journal-title":"Schweiz Med Wochenschau"},{"key":"BF03040356_CR16","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/oxfordjournals.ndt.a027671","volume":"11","author":"G Sunder-Plassmann","year":"1996","unstructured":"Sunder-Plassmann G, H\u00f6rl WH (1996) Safety of intravenous injection of iron saccharate in hemodialysis patients. Nephrol Dial Transplant 11: 1797\u20131802","journal-title":"Nephrol Dial Transplant"},{"key":"BF03040356_CR17","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/oxfordjournals.ndt.a027405","volume":"11","author":"A Zanen","year":"1996","unstructured":"Zanen A, Adriaansen HJ, van Bommel E, Posthuma R, de Jong G (1996) \u201cOversaturation\u201d of transferrin after intravenous ferric gluconate (Ferrlecit) in hemodialysis patients. Nephrol Dial Transplant 11: 820\u2013824","journal-title":"Nephrol Dial Transplant"},{"key":"BF03040356_CR18","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1053\/ajkd.2003.50141","volume":"41","author":"VW Folkert","year":"2003","unstructured":"Folkert VW, Michael B, Agarwal R, et al (2003) Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose administation. Am J Kidney Dis 41: 651\u2013657","journal-title":"Am J Kidney Dis"},{"key":"BF03040356_CR19","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1046\/j.1523-1755.2002.00314.x","volume":"61","author":"B Michael","year":"2002","unstructured":"Michael B, Coyne DW, Fishbane S, et al (2002) Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. Kidney Int 61: 1830\u20131836","journal-title":"Kidney Int"},{"key":"BF03040356_CR20","first-page":"1439","volume":"12","author":"P Geisser","year":"1992","unstructured":"Geisser P, Baer M, Schaub E (1992) Structure\/Histotoxicity relationship of parenteral iron preparations. Arzneimittel-Forschung\/Drug Research 12: 1439\u20131452","journal-title":"Arzneimittel-Forschung\/Drug Research"},{"key":"BF03040356_CR21","first-page":"357","volume":"114","author":"G Weiss","year":"2002","unstructured":"Weiss G (2002) Eisen, Infektion und An\u00e4mie \u2014 eine klassische Triade. Wien Klin Wochenschr 114: 357\u2013367","journal-title":"Wien Klin Wochenschr"}],"container-title":["Wiener Klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03040356.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03040356\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03040356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T03:34:03Z","timestamp":1684985643000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03040356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["BF03040356"],"URL":"https:\/\/doi.org\/10.1007\/bf03040356","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}